Search Results

There are 8272 results for: content related to: Pharmacokinetics of ganciclovir and valganciclovir in the adult horse

  1. The Role of Ganciclovir in Transplantation

    Immunotherapy in Transplantation: Principles and Practice

    Lyndsey J. Bowman, Daniel C. Brennan, Pages: 316–329, 2012

    Published Online : 19 APR 2012, DOI: 10.1002/9781444355628.ch21

  2. Single-Dose Pharmacokinetics of Valganciclovir in HIV- and CMV-Seropositive Subjects

    The Journal of Clinical Pharmacology

    Volume 39, Issue 8, August 1999, Pages: 800–804, Dr. Donald Jung and Albert Dorr

    Version of Record online : 8 MAR 2013, DOI: 10.1177/00912709922008452

  3. You have free access to this content
    Antiviral medications for preventing cytomegalovirus disease in solid organ transplant recipients

    Intervention Review

    The Cochrane Library

    Elisabeth M Hodson, Maleeka Ladhani, Angela C Webster, Giovanni FM Strippoli and Jonathan C Craig

    Published Online : 28 FEB 2013, DOI: 10.1002/14651858.CD003774.pub4

  4. You have free access to this content
    Cytomegalovirus

    American Journal of Transplantation

    Volume 4, Issue s10, October 2004, Pages: 51–58,

    Version of Record online : 25 OCT 2004, DOI: 10.1111/j.1600-6135.2004.00727.x

  5. Valganciclovir: A New Oral Alternative for Cytomegalovirus Retinitis in Human Immunodeficiency Virus-Seropositive Individuals

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 22, Issue 9, September 2002, Pages: 1124–1128, Dr. Marisel Segarra-Newnham and Dr. Martha I. Salazar

    Version of Record online : 17 JAN 2012, DOI: 10.1592/phco.22.13.1124.33527

  6. You have free access to this content
    Retrospective review of the incidence of cytomegalovirus infection and disease after liver transplantation in pediatric patients: Comparison of prophylactic oral ganciclovir and oral valganciclovir

    Liver Transplantation

    Volume 18, Issue 3, March 2012, Pages: 347–354, Ashley N. Bedel, Trina S. Hemmelgarn and Rohit Kohli

    Version of Record online : 24 FEB 2012, DOI: 10.1002/lt.22471

  7. You have free access to this content
    Valganciclovir: Recent Progress

    American Journal of Transplantation

    Volume 10, Issue 6, June 2010, Pages: 1359–1364, M. D. Pescovitz

    Version of Record online : 28 APR 2010, DOI: 10.1111/j.1600-6143.2010.03112.x

  8. You have free access to this content
    Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled Trial

    American Journal of Transplantation

    Volume 12, Issue 11, November 2012, Pages: 3021–3030, D. J. Winston, F. Saliba, E. Blumberg, M. Abouljoud, J. B. Garcia-Diaz, J. A. Goss, L. Clough, R. Avery, A. P. Limaye, B. G. Ericzon, M. Navasa, R. I. Troisi, H. Chen, S. A. Villano, M. E. Uknis and for the 1263–301 Clinical Study Group

    Version of Record online : 4 SEP 2012, DOI: 10.1111/j.1600-6143.2012.04231.x

    Corrected by:

    Erratum: Erratum

    Vol. 13, Issue 2, 529, Version of Record online: 28 JAN 2013

  9. You have free access to this content
    Population pharmacokinetics of valganciclovir prophylaxis in paediatric and adult solid organ transplant recipients

    British Journal of Clinical Pharmacology

    Volume 78, Issue 2, August 2014, Pages: 343–352, Heather E. Vezina, Richard C. Brundage and Henry H. Balfour Jr

    Version of Record online : 21 JUL 2014, DOI: 10.1111/bcp.12343

  10. You have free access to this content
    The Time Course of Development and Impact From Viral Resistance Against Ganciclovir in Cytomegalovirus Infection

    American Journal of Transplantation

    Volume 13, Issue 2, February 2013, Pages: 458–466, C. da Cunha-Bang, N. Kirkby, M. Sønderholm, S. S. Sørensen, H. Sengeløv, M. Iversen, A. Rasmussen, F. Gustafsson, C. M. Frederiksen, J. Kjær, A. Cozzi Lepri and J. D. Lundgren

    Version of Record online : 2 JAN 2013, DOI: 10.1111/ajt.12042

  11. You have free access to this content
    Efficacy and Safety of Valganciclovir vs. Oral Ganciclovir for Prevention of Cytomegalovirus Disease in Solid Organ Transplant Recipients

    American Journal of Transplantation

    Volume 4, Issue 4, April 2004, Pages: 611–620, Carlos Paya, Atul Humar, Ed Dominguez, Kenneth Washburn, Emily Blumberg, Barbara Alexander, Richard Freeman, Nigel Heaton, Mark D. Pescovitz and Valganciclovir Solid Organ Transplant Study Group

    Version of Record online : 25 FEB 2004, DOI: 10.1111/j.1600-6143.2004.00382.x

  12. Unexpectedly high inter- and intrapatient variability of Ganciclovir levels in children

    Pediatric Transplantation

    Volume 11, Issue 3, May 2007, Pages: 301–305, Jennifer Vethamuthu, Janusz Feber, Ann Chretien, Dagmar Lampe and Guido Filler

    Version of Record online : 24 JAN 2007, DOI: 10.1111/j.1399-3046.2006.00669.x

  13. Transport of valganciclovir, a ganciclovir prodrug, via peptide transporters PEPT1 and PEPT2

    Journal of Pharmaceutical Sciences

    Volume 89, Issue 6, June 2000, Pages: 781–789, Mitsuru Sugawara, Wei Huang, You-Jun Fei, Frederick H. Leibach, Vadivel Ganapathy and Malliga E. Ganapathy

    Version of Record online : 20 JUN 2000, DOI: 10.1002/(SICI)1520-6017(200006)89:6<781::AID-JPS10>3.0.CO;2-7

  14. Cost of prophylaxis in the management of cytomegalovirus infection in solid organ transplant recipients

    Clinical Transplantation

    Volume 21, Issue 4, July/August 2007, Pages: 441–448, Federico Oppenheimer, Miguel Gonzalez-Molina and Marta Rubio

    Version of Record online : 30 JUN 2007, DOI: 10.1111/j.1399-0012.2007.00612.x

  15. Hematologic complications of anti-CMV therapy in solid organ transplant recipients

    Clinical Transplantation

    Volume 23, Issue 3, June/July 2009, Pages: 295–304, Lara Danziger-Isakov and G. Mark Baillie

    Version of Record online : 18 DEC 2008, DOI: 10.1111/j.1399-0012.2008.00942.x

  16. A 42-year-old lung transplant patient with ganciclovir-resistant cytomegalovirus (CMV) infection

    Transplant Infectious Disease

    Volume 1, Issue 3, September 1999, Pages: 218–225, N. Basgoz

    Version of Record online : 5 JAN 2002, DOI: 10.1034/j.1399-3062.1999.010310.x

  17. You have free access to this content
    A Trial of Valganciclovir Prophylaxis for Cytomegalovirus Prevention in Lung Transplant Recipients

    American Journal of Transplantation

    Volume 5, Issue 6, June 2005, Pages: 1462–1468, Atul Humar, Deepali Kumar, Jutta Preiksaitis, Guy Boivin, Deborah Siegal, Jayne Fenton, Kathy Jackson, Sarah Nia and Dale Lien

    Version of Record online : 9 APR 2005, DOI: 10.1111/j.1600-6143.2005.00866.x

  18. Ganciclovir exposure under a 450 mg daily dosage of valganciclovir for cytomegalovirus prevention in kidney transplantation: a prospective study

    Clinical Transplantation

    Volume 24, Issue 6, November/December 2010, Pages: 794–800, Oriol Manuel, Manuel Pascual, Nancy Perrottet, Frédéric Lamoth, Jean-P. Venetz, Laurent A. Decosterd, Thierry Buclin and Pascal R. Meylan

    Version of Record online : 24 JAN 2010, DOI: 10.1111/j.1399-0012.2009.01205.x

  19. Ganciclovir Population Pharmacokinetics in Neonates Following Intravenous Administration of Ganciclovir and Oral Administration of a Liquid Valganciclovir Formulation

    Clinical Pharmacology & Therapeutics

    Volume 81, Issue 6, June 2007, Pages: 867–872, E P Acosta, R C Brundage, J R King, P J Sánchez, S Sood, V Agrawal, J Homans, R F Jacobs, D Lang, J R Romero, J Griffin, G Cloud, R Whitley, D W Kimberlin and For the National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group

    Version of Record online : 28 MAR 2007, DOI: 10.1038/sj.clpt.6100150

  20. You have free access to this content
    Monitoring plasma levels of ganciclovir in AIDS patients receiving oral ganciclovir as maintenance therapy for CMV retinitis

    Clinical Microbiology and Infection

    Volume 6, Issue 3, March 2000, Pages: 117–120, C. Piketty, C. Bardin, J. Gilquin, A. Gairard and F. Chast

    Version of Record online : 24 DEC 2001, DOI: 10.1046/j.1469-0691.2000.00014.x